Next Science Product Featured in Lifetime Channel Program on Treating Chronic Wounds
June 28, 2021
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Next Science (ASX:NXS), an innovative medical technology company and leader in treating biofilm-based infections in humans, today announced new educational broadcast content about chronic infections, which impact 17 million Americans each year. “The Balancing Act,” a lifestyle show that airs on the Lifetime channel, will feature a segment that discusses the costly and debilitating nature of these infections and how physicians can more effectively treat patients suffering from chronic wounds, including diabetic wounds, by using BLASTX, Next Science’s antimicrobial wound gel.
Help for those with COPD, promising news for our four-legged friends suffering from cancer, and a non-invasive way to sculpt our bodies.
ELIAS Animal Health's mission is to improve cancer treatment outcomes in veterinary patients through the advancement of innovative, scientifically-proven therapies.
Body sculpting does not have to be an invasive and taxing procedure. AirSculpt is a next-generation body contouring technology that removes and transfers fat using patented technology.